No Data
No Data
The industry is hotly discussing the future trends of nuclear medicine, will Hybrid NewCo become a new model for the RDC Industry to venture abroad? | Industry Observation
① Today, the 2025 Future XDC New Drug Conference is held in Chengdu; ② Executives from companies such as Baillie Tianheng and Kelun Botai, along with numerous experts and scholars in the industry, will jointly discuss cutting-edge technologies in ADC/nuclear drug development, overseas strategies, and other Topics.
Everbright: Import substitution is expected to accelerate, pay attention to the rising market share of domestic surgical robots.
Everbright stated that the import substitution is expected to accelerate, paying attention to the rise in market share of domestic surgical robots.
China Securities Co.,Ltd.: It is recommended to focus on the new growth and integration opportunities in the Industry.
China Securities Co.,Ltd. remains bullish on high-quality Innovative Drugs companies in 2025 and actively focuses on cutting-edge technologies in pharmaceuticals and medical devices.
Hong Kong stock Concept tracking | The National Medical Products Administration has published a request for opinions on the innovative development of high-end medical instruments. AI + Siasun Robot&Automation + Brain-computer Interface and other advanced
The National Medical Products Administration: Accelerate the revision of general standards in the fields of medical robots, AI medical instruments, high-end medical imaging equipment, etc.
Vincent Medical Holdings Limited (HKG:1612) Stock Catapults 26% Though Its Price And Business Still Lag The Market
VINCENT MED (01612.HK) subsidiary entered into a procurement agreement for health care and wellness products with VRDG.
On March 19, Gelonghui reports that VINCENT MED (01612.HK) announced that on March 19, 2025, its indirect subsidiary VME (as the purchaser) entered into a procurement agreement for healthcare and wellness products with VRDG (as the supplier). According to this agreement, VRDG has agreed to provide healthcare and wellness products to VME from March 19, 2025, to December 31, 2027 (including both start and end dates).